Entering text into the input field will update the search result below

Graybug Vision reports full data from mid-stage wet AMD trial

May 12, 2021 9:59 AM ETCalciMedica, Inc. (CALC) StockCALCBy: Dulan Lokuwithana, SA News Editor7 Comments
  • Graybug Vision (GRAY -7.2%) has reported the results from full-data analysis of the Phase 2b ALTISSIMO trial of GB-102 for the treatment of wet age-related macular degeneration (wet AMD).
  • Conducted across 33 sites in the U.S., the masked and controlled trial was designed

Recommended For You

About CALC Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
CALC--
CalciMedica, Inc.